PNC Financial Services Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
SL
PNC Financial Services Group's RCUS Position: Q3 2026 in Review
PNC Financial Services Group increased its Arcus Biosciences (RCUS) stake by 6.6% in Q3 2026, buying an estimated $13.5K and bringing the position to 7,735 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2497.
PNC Financial Services Group first reported a position in RCUS in Q2 2022 and has held it in 18 quarters since. The position peaked at $224K in Q2 2026. 137 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- PNC Financial Services Group held 7,735 shares of Arcus Biosciences worth $200K as of Q3 2026.
- PNC Financial Services Group bought 478 Arcus Biosciences shares in Q3 2026, an estimated $13.5K.
- Arcus Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #2497 holding.
- PNC Financial Services Group first reported a position in Arcus Biosciences in Q2 2022 and has held it in 18 quarters since.
- PNC Financial Services Group's Arcus Biosciences position peaked at $224K in Q2 2026.
- 137 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.